Comment from Pathway for Patient Health (www.Pathway4PH.org)

Summary: Pathway for Patient Health, a collaborative community, submitted detailed line-by-line comments and additional recommendations to improve the draft guidance on responding to FDA Form 483 observations. They advocate for a more risk-based, holistic approach to investigations, emphasizing patient safety, management responsibility, and the inclusion of practical tools like a decision tree.